Express Pharma - Express Pharma

Express Pharma–Nutrify Today Boardroom: Season 2 | EP 1

An accelerated assessment aims to speed up the European Medicines Agency’s (EMA) review of a market authorisation application

The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD)

Currently, Zaynich is undergoing a multinational Phase 3 study, which is expected to be completed by FY 2025

Pharmaceutical manufacturers like Boehringer Ingelheim, GSK, and AstraZeneca are participating in this initiative

Eugene Panfilov, Managing Director, Borzo, India

Arun Kedia, Managing Director, VAV Lipids

This alliance aims to rapidly deploy Orchid’s novel anti-infective invented in India to address the rising threat of antimicrobial…

Global quality experts call for strengthening quality culture and leveraging technological advancements

PharmaLytica 2024 offered a platform for stakeholders to engage in discussions covering the full spectrum of pharma machinery and…